← Leaderboards
Mohammad Saleem Bhat
University Of Wisconsin-Madison
$2,843,878
Attributed
$2,843,878
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $724.5K · FY2007–20$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,843,878 · 4
By mechanism
R01$1,767,920 · 1
R21$928,958 · 2
R03$147,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Christopher A Ahern$11,135,468
- Scott E Lindner$4,500,823
Others in their field
Top investigators on “Metastatic Prostate Cancer”
- David Heimbrook · Leidos Biomedical Research, Inc.$86,155,371
- Walter John Curran · Thomas Jefferson University$26,641,549
- Arul M Chinnaiyan · University Of Michigan At Ann Arbor$20,468,199
- Larry Arthur$17,525,000
- Cory Abate-Shen · Columbia University Health Sciences$16,894,858
- Daniel B Vigneron · University Of California, San Francisco$15,322,932
Research focus
Metastatic Prostate CancerCellsIn VitroGrowthMalignant Neoplasm Of ProstateBaseTumorMouse ModelNeoplastic CellTherapeutic TargetPlayPhenotypeNeoplasm MetastasisTherapeutic AgentsPublishingResistancePreventDistantSitePrimary NeoplasmMolecularMigrationProstate Cancer CellPathway Interactions
Grant awards (13)
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP$208,022
R01 · FY2020 · CA · contact PI
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP$155,620
R01 · FY2020 · CA · contact PI
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP$343,925
R01 · FY2019 · CA · contact PI
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP$354,563
R01 · FY2018 · CA · contact PI
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP$354,563
R01 · FY2017 · CA · contact PI
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP$351,227
R01 · FY2016 · CA · contact PI
Novel gene that determines metastatic phenotype in African-American men$199,999
R21 · FY2016 · CA · contact PI
Novel gene that determines metastatic phenotype in African-American men with PCa$173,232
R21 · FY2016 · CA · contact PI
Novel gene that determines metastatic phenotype in African-American men with PCa$208,567
R21 · FY2015 · CA · contact PI
Delaying the Hormone Refractory Prostate Cancer by a Dietary Triterpene Lupeol$183,811
R21 · FY2010 · CA · contact PI
Delaying the Hormone Refractory Prostate Cancer by a Dietary Triterpene Lupeol$163,349
R21 · FY2009 · CA · contact PI
Lupeol, A Novel Fuit and Vegetable Based Triterpene for Prostate Cancer$73,500
R03 · FY2008 · CA · contact PI
Lupeol, A Novel Fuit and Vegetable Based Triterpene for Prostate Cancer$73,500
R03 · FY2007 · CA · contact PI